The brain pacemaker is the biggest breakthrough in the treatment of Parkinson’s disease in recent years. If the clinical application of dopamine drugs is the first milestone in the treatment of Parkinson’s disease, the brain pacemaker is the second milestone in the treatment of Parkinson’s disease. It has been used in Europe for the treatment of movement disorders such as Parkinson’s disease since as early as 1987. It has passed the European CE and US FDA certifications and has been designated by the government as an effective solution for the treatment of Parkinson’s disease. It is a brain pacemaker implanted in the body that distributes weak electrical impulses to stimulate the relevant nuclei in the brain that control movement, inhibiting the abnormal brain nerve signals that cause Parkinson’s disease symptoms, thus eliminating the symptoms of Parkinson’s disease and restoring the patient’s original mobility. At present, the latest international research data show that the pacemaker can not only effectively control tremor, rigidity and motor retardation in Parkinson’s disease patients, but also greatly improve their quality of life, and reduce the dose of anti-Parkinson’s drugs, while eliminating the side effects caused by drug therapy. The brain pacemaker solves the problems of basic motor inability phenomenon, switching phenomenon, allodynia, and tremors caused by typical Parkinson’s disease where drug therapy is ineffective. This approach has the added benefit of slowing the progression of Parkinson’s disease and increasing the production of dopamine in the brain, and can be effective in controlling symptoms over time. As a result, more and more patients have been treated with pacemakers, especially for those patients for whom medication has become ineffective or for whom side effects of medication have occurred. There have been tens of thousands of successful treatments internationally, and with the rapid convergence of the domestic medical community with the international community, thousands of patients in China have also resumed their former lives and work after pacemaker implantation.